InvestorsHub Logo
Followers 0
Posts 56
Boards Moderated 0
Alias Born 12/14/2013

Re: None

Saturday, 01/11/2014 9:43:43 AM

Saturday, January 11, 2014 9:43:43 AM

Post# of 30393
ok lets be fair and be objective review this sale of Bioquant back in '11. read the news and what price it was sold for: see where it says a minimum of $5M"
well then how is it possible that in almost 3 years only $1.25M was receieved for a press release stating a minimum of $5M and a max of $20M would be generated for the sale.

SAN DIEGO, July 6, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that it has sold its wholly-owned subsidiary, Bio-Quant, Inc. ("Bio-Quant"), a specialty biotechnology Contract Research Organization ("CRO"), to BioTox Sciences ("BioTox"), a San Diego-based CRO. Under terms of the agreement, Apricus Bio will receive a minimum of $5 million in up-front and future earn-out payments, with the potential for as much as $20 million over the next ten years, based on BioTox's currently projected revenues. Additionally, Apricus Bio has retained all NexMed-related research conducted by Bio-Quant as well as the profitable Bio-Quant diagnostic kit business.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News